Literature DB >> 10937871

Nogo-A, a potent inhibitor of neurite outgrowth and regeneration.

A B Huber1, M E Schwab.   

Abstract

The lack of regrowth of injured neurons in the adult central nervous system (CNS) of higher vertebrates was accepted as a fact for many decades. In the last few years a very different view emerged; regeneration of lesioned fibre tracts in vivo could be induced experimentally, and molecules that are responsible for inhibition and repulsion of growing neurites have been defined. Mechanisms that link cellular phenomena like growth cone turning or growth cone collapse to intracellular changes in second messenger systems and cytoskeletal dynamics became unveiled. This article reviews recent developments in this field, focusing especially on one of the best characterised neurite out-growth inhibitory molecules found in CNS myelin that was recently cloned: Nogo-A. Nogo-A is a high molecular weight transmembrane protein and an antigen of the monoclonal antibody mAb IN-1 that was shown to promote long-distance regeneration and functional recovery in vivo when applied to spinal cord-injured adult rats. Nogo-A is expressed by oligodendrocytes in white matter of the CNS. With the molecular characterisation of this factor new possibilities open up to achieve structural and functional repair of the injured CNS.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10937871     DOI: 10.1515/BC.2000.053

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  29 in total

1.  NG2 is a major chondroitin sulfate proteoglycan produced after spinal cord injury and is expressed by macrophages and oligodendrocyte progenitors.

Authors:  Leonard L Jones; Yu Yamaguchi; William B Stallcup; Mark H Tuszynski
Journal:  J Neurosci       Date:  2002-04-01       Impact factor: 6.167

Review 2.  Neurotrophic factors, cellular bridges and gene therapy for spinal cord injury.

Authors:  L L Jones; M Oudega; M B Bunge; M H Tuszynski
Journal:  J Physiol       Date:  2001-05-15       Impact factor: 5.182

Review 3.  Strategies for identifying genes that play a role in spinal cord regeneration.

Authors:  M Wintzer; M Mladinic; D Lazarevic; C Casseler; A Cattaneo; J Nicholls
Journal:  J Anat       Date:  2004-01       Impact factor: 2.610

4.  Structure and axon outgrowth inhibitor binding of the Nogo-66 receptor and related proteins.

Authors:  William A Barton; Betty P Liu; Dorothea Tzvetkova; Philip D Jeffrey; Alyson E Fournier; Dinah Sah; Richard Cate; Stephen M Strittmatter; Dimitar B Nikolov
Journal:  EMBO J       Date:  2003-07-01       Impact factor: 11.598

Review 5.  Molecular and Cellular Mechanisms of Axonal Regeneration After Spinal Cord Injury.

Authors:  Erna A van Niekerk; Mark H Tuszynski; Paul Lu; Jennifer N Dulin
Journal:  Mol Cell Proteomics       Date:  2015-12-22       Impact factor: 5.911

6.  Vaccination with a Nogo-A-derived peptide after incomplete spinal-cord injury promotes recovery via a T-cell-mediated neuroprotective response: comparison with other myelin antigens.

Authors:  E Hauben; A Ibarra; T Mizrahi; R Barouch; E Agranov; M Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

7.  The effects of cold preservation and subimmunosuppressive doses of FK506 on axonal regeneration in murine peripheral nerve isografts.

Authors:  Terence M Myckatyn; Daniel A Hunter; Susan E Mackinnon
Journal:  Can J Plast Surg       Date:  2003

8.  HSV-mediated gene transfer of C3 transferase inhibits Rho to promote axonal regeneration.

Authors:  Zhigang Zhou; Xiangmin Peng; Peipei Chiang; Jeeyong Kim; Xiankui Sun; David J Fink; Marina Mata
Journal:  Exp Neurol       Date:  2012-06-26       Impact factor: 5.330

Review 9.  Cell therapy for spinal cord regeneration.

Authors:  Stephanie M Willerth; Shelly E Sakiyama-Elbert
Journal:  Adv Drug Deliv Rev       Date:  2007-10-05       Impact factor: 15.470

10.  The N-terminal domain of Nogo-A inhibits cell adhesion and axonal outgrowth by an integrin-specific mechanism.

Authors:  Fenghua Hu; Stephen M Strittmatter
Journal:  J Neurosci       Date:  2008-01-30       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.